Ads
related to: guardant reveal breast cancer
Search results
Results From The WOW.Com Content Network
On Thursday, Guardant Health (NYSE:GH) reported fourth-quarter adjusted EPS loss of 62 cents, compared to a loss of 64 cents a year ago, beating the consensus loss of 74 cents. The cancer ...
Guardant Health launched the early-stage cancer assay called Lunar for academic and biopharmaceutical research in 2019. [ 39 ] Japan's Ministry of Health, Labour and Welfare granted regulatory approval of Guardant360 CDx as a companion diagnostic "for identifying patients with metastatic non-small cell lung cancer who may benefit from treatment ...
Guardant Health said its blood test to detect cancer that starts in the colon or rectum got an approval from the U.S. Food and Drug Administration, with the test moving closer toward gaining ...
Olivia Munn continues to get candid about her harrowing experience with breast cancer. On Tuesday's episode of The Kelly Clarkson Show, the 43-year-old actress opens up about the moment she ...
In February 2007, the U.S. Food and Drug Administration (FDA) cleared the MammaPrint test for use in the U.S. for lymph node negative breast cancer patients of all ages, ER negative or ER positive, with tumors of less than 5 cm. [19] MammaPrint can be considered as a part of standard of care disease management for early stage breast cancer and ...
Talasaz was first the president and chief technology officer of Guardant Health. [10] [11] He held the president, chief financial officer, and chief operating officer positions in 2019, when he and Eltoukhy collectively held 12 percent of Guardant Health's stock. [12] [13] In 2021, both spent $10 million to purchase additional shares of the ...
Ads
related to: guardant reveal breast cancer